Charnelda L Gray,Carole Gardner
Charnelda L Gray
Drug use evaluation of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic [0.03%]
药师与非药师内科医师西他列汀用药评估的比较研究：一家私人多专科诊所内的部门调查
M Shawn McFarland,L Brian Cross,Benjamin Gross et al.
M Shawn McFarland et al.
Background: Sitagliptin is recommended for initial and maintenance dosing at 100 mg daily. Downward dose adjustment is recommended in patients with moderate or severe renal insufficiency. ...
Scott A Strassels
Scott A Strassels
Background: Prescription opioid abuse and its associated costs are a problem in the United States, with significant epidemiologic and economic consequences. The breadth and depth of these consequences are not fully unders...
Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis [0.03%]
比较针对复发型多发性硬化症一线治疗的修正疾病进程药物的成本效益
Lawrence D D Goldberg,Natalie C Edwards,Contessa Fincher et al.
Lawrence D D Goldberg et al.
Background: Multiple sclerosis (MS) is an inflammatory autoimmune disorder of the central nervous system that primarily afflicts young adults. Approximately 400,000 people in the United States are affected by MS. Although...
Association between the use of 4 recommended drug categories and patient perceptions of health status following an ACS event [0.03%]
四种推荐药物的使用与急性冠脉综合征事件后患者对自身健康状态认知之间的关系研究
Steven V Erickson,Krishna Rangarajan,Eva M Kline-Rogers et al.
Steven V Erickson et al.
Background: Four categories of medication have been shown to reduce mortality following an acute coronary syndrome (ACS) event: (a) antiplatelets, (b) beta-blockers, (c) statins, and (d) angiotensin-converting enzyme (ACE...
Improving cost-effectiveness of and outcomes from drug therapy in patients with atrial fibrillation in managed care: role of the pharmacist [0.03%]
药房管理人员改善药物治疗的性价比和收益：心房颤动患者的案例研究
Samuel G Johnson
Samuel G Johnson
Background: The medical care costs for procedures, medications, and testing associated with atrial fibrillation (AF) in the United States are high and projected to increase markedly in the future as the number of American...
Pharmacologic management of atrial fibrillation: established and emerging options [0.03%]
房颤的药物治疗：现有的和新兴的选择
James S Kalus
James S Kalus
Background: In patients with atrial fibrillation (AF), antiarrhythmic drug therapy currently plays a greater role in maintaining sinus rhythm after cardioversion than it does in converting AF to sinus rhythm. Amiodarone i...
Cynthia A Sanoski
Cynthia A Sanoski
Background: Atrial fibrillation (AF) is a common, age-related arrhythmia that disproportionately affects men, adversely affects quality of life, and causes considerable morbidity and mortality. ...
AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0) [0.03%]
2009年版美国医疗保健协会药物支付方式指南(第二版)
Academy of Managed Care Pharmacy
Academy of Managed Care Pharmacy
The methods by which the U.S. health care system pays for prescription drugs have faced increasing scrutiny in recent years. Two key developments have emerged: (a) congressional enactment of important changes in the basis for payments for p...
Adding diagnosis codes to prescriptions: lessons learned from a quality improvement project [0.03%]
从质量改进项目中学习到的开具处方诊断经验教训
Ankur Ramesh Shah,Mark D Boesen,Kimberly D Harris-Salamone et al.
Ankur Ramesh Shah et al.